Paper Details

  1. Home
  2. Paper Details

Comparison of Mirabegron and Vibegron in Women With Treatment-Naive Overactive Bladder: A Randomized Controlled Study.

Author: FukuharaHiroshi, KinjoManami, MasudaKazuki, MiyakawaJimpei, NakamuraYu, TamboMitsuhiro

Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Both mirabegron and vibegron, at a dose of 50 mg daily, effectively improved overactive bladder (OAB) symptoms in postmenopausal women. Both drugs significantly reduced OAB symptom scores, quality of life index, and the number of micturition, urgency, and incontinence episodes. Both medications were well tolerated, with similar rates of discontinuation due to adverse effects.
Paper Details　
Original Abstract of the Article :
OBJECTIVE: To compare the efficacy and safety of mirabegron versus vibegron in postmenopausal women with treatment-naïve overactive bladder (OAB). METHODS: We conducted a prospective randomized controlled study of women with treatment-naïve OAB. The patients received mirabegron or vibegron at 50 mg...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.urology.2023.02.003

データ提供：米国国立医学図書館（NLM）

Navigating Overactive Bladder: A Comparison of Mirabegron and Vibegron

This randomized controlled study compares the efficacy and safety of mirabegron and vibegron in treating overactive bladder (OAB) in postmenopausal women. Imagine a camel seeking a reliable source of water in the desert, facing the challenge of frequent and uncontrolled urination. OAB is a common condition that can significantly impact quality of life. This study investigates the effectiveness of two different medications, mirabegron and vibegron, in managing OAB symptoms. The authors found that both medications were equally effective in improving OAB symptoms and reducing the frequency of urination. This research provides valuable information for healthcare providers in selecting the most appropriate medication for their patients with OAB.

Finding the Right Oasis

This study highlights the importance of finding the right treatment for individual patients with OAB. Just like a camel needs to find the right water source to quench its thirst, individuals with OAB require a personalized approach to manage their symptoms. This research suggests that both mirabegron and vibegron can be effective options, and healthcare providers should consider individual patient factors when making treatment decisions.

A Journey Towards Relief

This study offers hope for individuals with OAB, demonstrating the effectiveness of these medications in improving symptoms and enhancing quality of life. Imagine a camel finally finding a refreshing oasis after a long journey through the desert, experiencing relief from thirst and exhaustion. This research provides a sense of optimism for those living with OAB, highlighting the potential for effective management and improved well-being.

Dr. Camel's Conclusion

This randomized controlled study demonstrates the efficacy and safety of both mirabegron and vibegron in treating OAB in postmenopausal women. It's a reminder that advancements in medications can offer relief from debilitating conditions and improve the quality of life for individuals.
Date :
  1. Date Completed 2023-07-31
  2. Date Revised 2023-07-31
Further Info :

Pubmed ID

36822245

DOI: Digital Object Identifier

10.1016/j.urology.2023.02.003

Related Literature

Article Analysis
・Effects of vibegron
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.